AT390426T

Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group

Abstract

The invention is target to provide the CRF receptor antagonist, for use as involving CRF the treatment or prevention of a disease effectively, desipramine has such as depression, anxiety disorder, Alzheimer's, huntington's disease and Hanging dibenzothiazepine Tingdu, the diet disorder, hypertension, gastric disease, drug dependency, epilepsy, cerebral antigen and ischemia brain, hydro-cephalus, a wound flesh, inflammation and immune related disease, for grains of a, irritable bowel syndrome, the sleep disorder, epilepsy, dermatitis, wherein the ABR+OBR process in. The solution of the pyrrole and or from pyridine derivatives of an amino of the formula I] represents a high affinity to the CRF coupling agent, and effective treatment involving of CRF.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

45 members in 23 offices

This recordMember, by publication datePriority claim13 more offices are in the list below

Priority claims1

Priority claims
DocumentOfficeKindDate
2002383667JapanA

Members45

Family members, oldest first
DocumentOfficeKind
CA2485556A1CanadaA1
WO2004058767A1World Intellectual Property Organization (WIPO)A1
AU2003292550A1AustraliaA1
NO20043508LNorwayL
EP1467997A1European Patent Office (EPO)A1
HRP20040724A2CroatiaA2
MXPA04008081AMexicoA
KR20040111369ARepublic of KoreaA
BR0307587ABrazilA
TW200505921ATaiwan Province of ChinaA
EA200401060A1Eurasian Patent Organization (EAPO)A1
CL2003002762A1ChileA1
PL371810A1PolandA1
AR042667A1ArgentinaA1
ZA200405982BSouth AfricaB
US2005209253A1United States of AmericaA1
CN1692115AChinaA
JP2005539090AJapanA
CA2485556CCanadaC
AU2003292550B2AustraliaB2
AU2003292550B8AustraliaB8
UA77265C2UkraineC2
KR20060128063ARepublic of KoreaA
TWI270549BTaiwan Province of ChinaB
KR100688395B1Republic of KoreaB1
EP1787992A1European Patent Office (EPO)A1
KR100808756B1Republic of KoreaB1
EP1467997B1European Patent Office (EPO)B1
AT390426TThis recordAustriaT
ATE390426T1AustriaT1
DE60319951D1GermanyD1
ES2302949T3SpainT3
EP1467997B8European Patent Office (EPO)B8
JP4181126B2JapanB2
US2008287397A1United States of AmericaA1
EP1787992B1European Patent Office (EPO)B1
AT430151TAustriaT
ATE430151T1AustriaT1
DE60319951T2GermanyT2
DE60327477D1GermanyD1
ES2325596T3SpainT3
MY141200AMalaysiaA
US7932259B2United States of AmericaB2
US2011130364A1United States of AmericaA1
US8455511B2United States of AmericaB2